AP NEWS

5th Pharmacovigilance Conference 2019 (London, United Kingdom - February 12-13, 2019) - ResearchAndMarkets.com

November 23, 2018
The “5th Pharmacovigilance Conference 2019” conference has been added to ResearchAndMarkets.com’s offering.According to research, the global pharmacovigilance market was valued at $2.1 billion in 2012 and is estimated to reach a market worth $5 billion in 2019, at a CAGR of 12.9% from 2013 to 2019. The guidelines for the appropriate implementation of drug safety reporting have been formulated by regulatory authorities such as the WHO and the FDA, who are aiding in enhancement of the overall pharmacovigilance activities. Based on the type of service providers, in-house and contract outsourcing pharmacovigilance services account for the largest market share of 50.8% in 2012 and is forecast to grow at a healthy growth rate of 15.5% from 2013 to 2019. Geographically, North America constituted the largest market for global pharmacovigilance in 2012; however, Asia-Pacific is predicted to foresee the highest growth rate of 15.2% from 2013 to 2019. This growth has been attributed to a large population base, low healthcare cost and high patient enrollment. According to market research, leading market players include Accenture, Bristol-Myers Squibb, Covance, Cognizant Technology Solutions, Icon, iGATE, Novartis International, Parexel International, PRA, PPD, Pfizer, Quintiles Transnational and Wipro.Conference Coverage 2 days of informative, scientific and business development presentations, workshops, 1 to 1 meetings, speed networking sessions and interactive corporate exhibition.

Over 50 attendees representing leading pharmaceutical organisations and global biotechnology companies, and internationally renowned academic institutions.

Presentations, case studies, workshops and panel discussions focused on the key issues in new harmonization initiatives, benefit risk optimization and legislation.

One to one meetings, exhibition and informal networking opportunities.

4 Interactive Main Topics

New strategies in benefit risk optimization, risk communication, labelling & packaging, and harmonizationAddressing drug counterfeiting issues & evaluating possible measures to combat & protect consumersEU and US and Asian reforms in pharmacovigilance legislationPreparing for product specific inspections & compliance monitoring by authorities

Agenda

Day 1

08:30 - Coffee and registration - An opportunity to meet and to network with your conference colleagues

09:30 - Chairperson opening remarks

09:40 - Monitoring of Risk Minimisation Measures

10:20 - PV Aspects of Patient Support/Market Research Programmes and other Externally Facing Activites

11:00 - Morning Coffee/Tea & Discussion

11:30 - Use of real-world evidence (RWE) in pharmacovigilance

11:50 - Post Registration Trials-role in PV

12:30 - Networking luncheon

13:40 - Panel Discussion - Future of PV - Where are we heading?

14:30 - Effective risk management: strategies’s to leverage patient safety

15:10 - Afternoon Tea/Coffee

15:30 - Challenges maintaining compliance and effective PV operations in a changing world?

16:10 - Automated PV data processing and its game changing prospect

16:50 - Chairperson’s closing remarks and end of conference

17:00 - 18:00 - Networking Drinks Session

Day 2

08:30 - Coffee and registration - An opportunity to meet and to network with your conference colleagues

09:30 - Chairperson opening remarks

09:40 - Integrating Signal and Risk Management from a Small to Medium sized company’s perspective

10:20 - RMP’s and updates to GVP2 / dilemmas with Core and Local RMP’s

10:50 - Morning Coffee/Tea & Discussion

11:10 - Keynote Panel Discussion - Enhancing communications between - Sponsor - Site - CRO & Patients

11:50 - PV in low & middle income countries & how high income countries and the industry can do more to improve patient safety in these resource scarce settings

12:30 - Networking luncheon

13:30 - Panel Discussion - Implementing risk minimization procedures - Making sure we succeed

14:10 - Challenges maintaining compliant and effective PV operations in a changing world

14:50 - Practical Advice on the of principles of GVP Rev 2

15:20 - Afternoon Tea/Coffee

15:40 - Why does pharmacovigilance sometimes fail and where/could the fault lie?

16:20 - Panel Discussion: Keeping abreast with the changing regulations of PV

17:00 - 17:10 - Chairperson’s closing remarks and end of the conferenceFor more information about this conference visit https://www.researchandmarkets.com/research/dgvvhq/5th?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181123005108/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Drug Discovery

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/23/2018 06:59 AM/DISC: 11/23/2018 06:59 AM

http://www.businesswire.com/news/home/20181123005108/en

AP RADIO
Update hourly